UTHR

United Therapeutics (UTHR)

About United Therapeutics (UTHR)

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.

Details

Daily high

$489.50

Daily low

$481.95

Price at open

$483.81

52 Week High

$519.99

52 Week Low

$266.98

Market cap

20.6B

Dividend yield

0.00%

Volume

297,163

Avg. volume

344,400

P/E ratio

18.15

United Therapeutics News